This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Ratings

10 Best Healthcare Equipment Stocks for

Top Rated Stocks

Every day TheStreet Ratings produces a list of the top rated stocks. These 10 healthcare equipment stocks are rated highest by TheStreet Ratings' value-focused stock rating model.

Equity Top: Healthcare Equipment


Source: TheStreet Ratings

Best Investments for

Healthcare Equipment

It's almost cruel to see Al Mann being forced back into the CEO role at MannKind, but the company's near-total collapse demands it.
11/20/15 10:36AM
The signal of activity Sage Therapeutics sees with SAGE-547 in essential tremor may turn out to be real or a mirage.
9/3/15 6:01AM
Titan and its partner will resubmit Probuphine for FDA approval later this year.
6/8/15 7:01AM
As the CEO of a struggling stem-cell therapy company, Hedrick needs to don brightly colored pom-poms just to grab investors' attention.
4/8/15 2:51PM
Plans to seek U.S. approval for the Ocular device, known as OTX-DP are now up in the air.
4/6/15 5:22PM
In April, Celladon is expecting results from a mid-stage study of a gene therapy aiming to improve the pumping ability of the heart in patients with advanced heart failure.
3/25/15 10:06AM
Ocular hasn't conducted clinical trials that would demonstrate that OTX-DP is any better than eye drops in reducing swelling and pain in the eye.
3/10/15 10:17AM
The Securities and Exchange Commission's top cop wants drug companies to be more transparent with investors about their dealings with the U.S. Food and Drug Administration.
3/4/15 1:08PM
Biotech columnist Adam Feuerstein answers readers' questions about health care.
1/23/15 6:00AM
The timing of the Afrezza commercial launch is still a mystery following Sanofi's presentation.
1/12/15 1:35PM
Good calls: Vertex, InterMune, Chelsea, Galena, Exact Sciences. The bad calls: Avanir, Amarin, Exelixis and the bursting biotech stock bubble.
12/19/14 9:02AM
Biotech columnist Adam Feuerstein answers readers' questions about health care.
12/5/14 6:00AM
Biotech columnist Adam Feuerstein answers readers' questions about health care.
11/21/14 6:00AM
Not everyone is convinced that the new Sanofi CEO will remain committed to MannKind and its inhaled insulin Afrezza.
11/4/14 1:40PM
Biotech columnist Adam Feuerstein answers readers' questions about health care.
10/17/14 7:05AM

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Markets

Chart of I:DJI
DOW 15,973.84 +313.66 2.00%
S&P 500 1,864.78 +35.70 1.95%
NASDAQ 4,337.5120 +70.6750 1.66%
Top Rated Stocks Top Rated Funds Top Rated ETFs